Cardioprotection of cancer patients receiving cardiotoxic chemotherapy — current status
Certain drugs used for the treatment of cancer can have a toxic effect on various organs and tissues, including the heart. Not only high-dose monotherapy can lead to damage to the heart muscle, but also a combination of two or three chemotherapy drugs can do so. Cancer patients receiving combination...
Main Authors: | Anton K. Peresada, David P. Dundua, Anna G. Kedrova, Irina N. Oleynikova, Anna V. Masterkova |
---|---|
Format: | Article |
Language: | English |
Published: |
Eco-vector
2024-01-01
|
Series: | Клиническая практика |
Subjects: | |
Online Access: | https://journals.eco-vector.com/clinpractice/article/viewFile/567924/pdf |
Similar Items
-
The use of quadrotherapy of chronic heart failure in cancer patients (case series)
by: Anton K. Peresada, et al.
Published: (2023-07-01) -
Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines
by: Aditi A. Bhagat, et al.
Published: (2023-12-01) -
The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
by: Inbar Nardi Agmon, et al.
Published: (2022-02-01) -
Cardioprotection From Cardiotoxicity
by: Guilherme H. Oliveira, MD, MBA
Published: (2019-09-01) -
Cardioprotective effect of thiotriazoline in cancer patients
by: A. V. Koltsov, et al.
Published: (2023-02-01)